2 4-dichlorobenzyl alcohol
UkraineDrugs containing this active substance
-
The preparation is used for the local treatment of infectious and inflammatory diseases of the oral cavity and pharynx, if they are accompanied by sore throat, hoarseness, or difficulty swallowing.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg menthol 5.4 mg anethole 2.4 mg peppermint oil 0.6 mg ATC: R02AA20
Manufacturer: Dr. Theiss Naturwaren GmbH (marketing authorization holder for batch release of finished medicinal product)
-
The preparation is used for the local treatment of infectious and inflammatory diseases of the oral cavity and pharynx, when there is a sore throat, hoarseness, or difficulty swallowing.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg menthol 5.4 mg anethole 2.4 mg peppermint oil 0.6 mg ATC: R02AA20
Manufacturer: Dr. Theiss Naturwaren GmbH (marketing authorization holder for batch release of finished medicinal product)
-
The preparation is used for the local treatment of infectious and inflammatory diseases of the oral cavity and pharynx, when there is a sore throat, hoarseness, or difficulty swallowing.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg menthol 5.4 mg anethole 2.4 mg peppermint oil 0.6 mg ATC: R02AA20
Manufacturer: Dr. Theiss Naturwaren GmbH (marketing authorization holder for batch release of finished medicinal product)
-
The preparation is used for the local treatment of infectious and inflammatory diseases of the oral cavity and pharynx, when there is a sore throat, hoarseness, or difficulty swallowing.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg menthol 5.4 mg anethole 2.4 mg peppermint oil 0.6 mg ATC: R02AA20
Manufacturer: Dr. Theiss Naturwaren GmbH (marketing authorization holder for batch release of finished medicinal product)
-
The preparation is used for the local treatment of infectious and inflammatory diseases of the oral cavity and pharynx, when there is a sore throat, hoarseness, or difficulty swallowing.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg menthol 5.4 mg anethole 2.4 mg peppermint oil 0.6 mg ATC: R02AA20
Manufacturer: Dr. Theiss Naturwaren GmbH (marketing authorization holder for batch release of finished medicinal product)
-
The drug is used for the symptomatic treatment of oral and throat infections, specifically to relieve severe throat pain.
Form: lozenges
Active substance Dosage lidocaine 2 mg amylmetacresol 0.6 mg 2 4-dichlorobenzyl alcohol 1.2 mg ATC: R02AA03
Manufacturer: LOZIS PHARMACEUTICALS S.L. (manufacturing, primary and secondary packaging, quality control, batch release)
-
The drug is used for the symptomatic treatment of oral and throat infections, particularly in cases of severe sore throat.
Form: lozenges
Active substance Dosage lidocaine 2 mg amylmetacresol 0.6 mg 2 4-dichlorobenzyl alcohol 1.2 mg ATC: R02AA03
Manufacturer: LOZIS PHARMACEUTICALS S.L. (manufacturing, primary and secondary packaging, quality control, batch release)
-
The drug is used for the symptomatic treatment of oral and throat infections, specifically for the relief of severe sore throat.
Form: lozenges
Active substance Dosage lidocaine 2 mg amylmetacresol 0.6 mg 2 4-dichlorobenzyl alcohol 1.2 mg ATC: R02AA03
Manufacturer: LOZIS PHARMACEUTICALS S.L. (manufacturing, primary and secondary packaging, quality control, batch release)
-
The drug is used for the local treatment of infectious and inflammatory diseases of the mouth, throat, and larynx, such as stomatitis, gingivitis, tonsillitis, pharyngitis, laryngitis, and the early stages of tonsillitis.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg amylmetacresol 0.6 mg levomenthol 5.9 mg ATC: R02AA20
Manufacturer: Divafarma GmbH (batch release)
-
The product is used for the supportive treatment of pharyngeal mucosal inflammation accompanied by sore throat, redness, or swelling.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg amylmetacresol 0.6 mg levomenthol 5.9 mg ATC: R02AA20
Manufacturer: Divafarma GmbH (responsible for batch release)
-
The product is used for the supportive treatment of pharyngeal mucosal inflammation when there is throat pain, redness, or swelling.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg amylmetacresol 0.6 mg levomenthol 5.9 mg ATC: R02AA20
Manufacturer: Divafarma GmbH (responsible for batch release)
-
The drug is used for the local treatment of infectious and inflammatory diseases of the mouth, throat, and larynx, such as stomatitis, gingivitis, tonsillitis, pharyngitis, laryngitis, and the early stages of tonsillitis.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg amylmetacresol 0.6 mg levomenthol 5.72 mg ATC: R02AA20
Manufacturer: Divafarma GmbH (batch release)
-
The product is used as an antiseptic to relieve acute sore throat pain.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg amylmetacresol 0.6 mg ATC: R02AA03
Manufacturer: Reckitt Benckiser Healthcare International Limited
-
The product is used for the symptomatic treatment of infectious and inflammatory diseases of the oral cavity and throat.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg amylmetacresol 0.6 mg ATC: R02AA03
Manufacturer: Reckitt Benckiser Healthcare International Limited
-
The product is used for the symptomatic treatment of oral and throat infections, particularly in cases of severe sore throat.
Form: lozenges
Active substance Dosage lidocaine 10 mg amylmetacresol 0.6 mg 2 4-dichlorobenzyl alcohol 1.2 mg ATC: R02AA03
Manufacturer: Reckitt Benckiser Healthcare International Limited
-
The product is used to relieve sore throat pain and for the symptomatic treatment of oral and throat infections.
Form: spray, oromucosal
Active substance Dosage amylmetacresol 0.223 g/100 ml 2 4-dichlorobenzyl alcohol 0.446 g/100 mL lidocaine 0.6 g/100 mL ATC: R02AA03
Manufacturer: Delpharm Bladel B.V.
-
This product is used as an antiseptic to relieve sore throat pain.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg amylmetacresol 0.6 mg ATC: R02AA03
Manufacturer: Reckitt Benckiser Healthcare International Limited
-
The lozenges are used for the symptomatic treatment of infectious and inflammatory diseases of the oral cavity and throat.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg amylmetacresol 0.6 mg ATC: R02AA03
Manufacturer: Reckitt Benckiser Healthcare International Limited
-
The drug is used for the symptomatic treatment of infectious and inflammatory diseases of the oral cavity and throat, as well as at the first signs of a cold accompanied by a sore throat and nasal congestion.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg amylmetacresol 0.6 mg levomenthol 8 mg ATC: R02AA03
Manufacturer: Reckitt Benckiser Healthcare International Limited
-
The drug is used for the symptomatic treatment of infectious and inflammatory diseases of the oral cavity and throat.
Form: lozenges
Active substance Dosage 2 4-dichlorobenzyl alcohol 1.2 mg amylmetacresol 0.6 mg sodium ascorbate 74.9 mg ascorbic acid 33.5 mg ATC: R02AA03
Manufacturer: Reckitt Benckiser Healthcare International Limited
-
The drug is used for the symptomatic treatment of infectious and inflammatory diseases of the oral cavity and throat.
Form: lozenges
Active substance Dosage amylmetacresol 0.6 mg 2 4-dichlorobenzyl alcohol 1.2 mg ATC: R02AA20
Manufacturer: Maxon Healthcare Pvt. Ltd.
-
The drug is used for the symptomatic treatment of infectious and inflammatory diseases of the oral cavity and throat.
Form: lozenges
Active substance Dosage amylmetacresol 0.6 mg 2 4-dichlorobenzyl alcohol 1.2 mg ATC: R02AA20
Manufacturer: Maxon Healthcare Pvt. Ltd.
-
The drug is used for the symptomatic treatment of infectious and inflammatory diseases of the oral cavity and throat.
Form: lozenges
Active substance Dosage amylmetacresol 0.6 mg 2 4-dichlorobenzyl alcohol 1.2 mg ATC: R02AA20
Manufacturer: Maxon Healthcare Pvt. Ltd.
-
The drug is used for the symptomatic treatment of infectious and inflammatory diseases of the oral cavity and throat.
Form: lozenges
Active substance Dosage amylmetacresol 0.6 mg 2 4-dichlorobenzyl alcohol 1.2 mg ATC: R02AA20
Manufacturer: Maxon Healthcare Pvt. Ltd.